Results 81 to 90 of about 14,200 (285)

Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ database

open access: yesBMC Gastroenterology, 2013
Background Although high non-adherence to medication has been noticed for ulcerative colitis (UC), little is known about adherence to mesalamine treatments and determinants that can predict adherence.
Lachaine Jean   +3 more
doaj   +1 more source

Box-Behnkenov eksperimentalni dizajn u izradi pektin-kompritol ATO 888 obloženih tableta za ciljanu isporuku mesalamina u kolon [PDF]

open access: yes, 2010
The aim of this study was to investigate the combined influence of 3 independent variables in the compression coated tablet of mesalamine for ulcerative colitis. A 3-factor, 3-level Box-Behnken design was used to derive a second order polynomial equation
JAYVADAN K. PATEL   +2 more
core   +2 more sources

Fibers and Polyphenols in Diverticular Disease: From Pathophysiology to Management

open access: yesNeurogastroenterology &Motility, Volume 37, Issue 12, December 2025.
ABSTRACT Backgrounds Diverticular disease, particularly symptomatic uncomplicated diverticular disease (SUDD), significantly impacts patient quality of life and is increasing in prevalence, especially in Western countries. While its pathophysiology is multifactorial, diet—specifically low fiber intake—has been implicated as a key modifiable factor in ...
Claudia Marinaccio   +8 more
wiley   +1 more source

Design, Development, and Optimisation of Smart Linker Chemistry for Targeted Colonic Delivery—In Vitro Evaluation

open access: yesPharmaceutics, 2023
Drug targeting is necessary to deliver drugs to a specific site of action at a rate dictated by therapeutic requirements. The pharmacological action of a drug can thereby be optimised while minimising adverse effects.
Heba S. Abd-Ellah   +3 more
doaj   +1 more source

Tumor Necrosis Factor Inhibitors and Risk of Serious Infections in Pregnant Women With Chronic Inflammatory Diseases

open access: yesACR Open Rheumatology, Volume 7, Issue 11, November 2025.
Objective Tumor necrosis factor inhibitors (TNFi) are used by over 20% of pregnant women with chronic inflammatory diseases, which could further impede immune function and increase the risk of infections that require hospitalization. We assessed the risk of serious infections during pregnancy and postpartum between women exposed and unexposed to TNFi ...
Leah K. Flatman   +6 more
wiley   +1 more source

Analgesic Management of Pain in Elite Athletes: A Systematic Review [PDF]

open access: yes, 2018
Objective: To identify the prevalence, frequency of use, and effects of analgesic pain management strategies used in elite athletes. Design: Systematic literature review.
Danielson, Elizabeth C.   +6 more
core   +1 more source

Tackling the Threat of Cancer Due to Pathobionts Producing Colibactin: Is Mesalamine the Magic Bullet?

open access: yesToxins, 2021
Colibactin is a genotoxin produced primarily by Escherichia coli harboring the genomic pks island (pks+ E. coli). Pks+ E. coli cause host cell DNA damage, leading to chromosomal instability and gene mutations.
Min Tang-Fichaux   +3 more
semanticscholar   +1 more source

Multiple Sampling Capsule Robot for Studying Gut Microbiome

open access: yesAdvanced Intelligent Systems, Volume 7, Issue 11, November 2025.
A multiple sampling capsule robot (MSCR) is developed for longitudinal gut microbiome analysis. Employing electromagnetic field control, the MSCR can locomote actively, precisely align the selected channel, and collect up to six microbiome samples with minimal cross‐contamination.
Sanghyeon Park   +3 more
wiley   +1 more source

Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels [PDF]

open access: yes, 2015
INTRODUCTION: Oral formulations of 5-aminosalicylic acid (5-ASA) for treatment of ulcerative colitis have been developed to minimize absorption prior to the drug reaching the colon.
Adeyinka Abinusawa, Srini Tenjarla
core   +1 more source

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX® mesalamine

open access: yesClinical Pharmacology: Advances and Applications, 2012
Kavinderjit Nanda, Alan C MossCenter for Inflammatory Bowel Disease, BIDMC/Harvard Medical School, Boston, MA, USAAbstract: Ulcerative colitis (UC) is a chronic inflammatory disease of the colon that typically manifests as diarrhea, abdominal pain, and ...
Nanda K, Moss AC
doaj  

Home - About - Disclaimer - Privacy